GSK Chair, Sir Jon Symonds has 10 identities and fails to declare National Centre for Universities and Business, Condorcet Partners, Condorcet GP LLP, Quality by Randomization and EA Group Holdings.

Clone identity fraud

A search on the name Sir Jonathan Richard Symonds in Companies House returns ten registered identities, with the same name and date of birth, February 1959, see image 1.

Image 1. Search results for Sir Jonathan Richard Symonds in Companies House.

I allege that he purports to be 10 people for the purpose of audits. He holds the following directorships:

Jonathan Richard SYMONDS identity 1: SEQIRUS VACCINES HOLDINGS LIMITED, SEQIRUS VACCINES LIMITED, NOVARTIS UK LIMITED, NOVARTIS PHARMACEUTICALS UK LIMITED Appointed on 31 March 2010 Resigned on 20 June 2013;

Jonathan Richard SYMONDS Identity 2: HSBC HOLDINGS PLC, HSBC BANK PLC Appointed on 14 April 2014 Resigned on 18 February 2020 and 6 August 2018;

Jonathan Richard SYMONDS Identity 3: GENOMICS ENGLAND LIMITED Role ACTIVE Appointed on 22 October 2013;

Jonathan Richard SYMONDS Identity 4: NATIONAL CENTRE FOR UNIVERSITIES AND BUSINESS Role ACTIVE Appointed on 8 December 2022;

Jonathan Richard SYMONDS Identity 5: GSK PLC Role ACTIVE Appointed on 1 September 2019;

Jonathan Richard SYMONDS Identity 6: CONDORCET PARTNERS LIMITED Role ACTIVE Appointed on 30 October 2015 and CONDORCET GP LLP Role ACTIVE LLP Designated Member Appointed on 22 January 2015;

Jonathan SYMONDS Identity 7: QUALITY BY RANDOMIZATION LIMITED Role ACTIVE Appointed on 9 December 2020; and,

Jonathan SYMONDS Identity 8: EA GROUP HOLDINGS LTD Role ACTIVE Appointed on 16 August 2022.

Jonathan Richard SYMONDS Identity 9: QINETIQ GROUP PLC Appointed on 28 February 2003 Resigned on 30 June 2004

DIAGEO PLC Appointed on 1 May 2004 Resigned on 16 October 2007

ASTRAZENECA PLC Appointed on 1 October 1997 Resigned on 31 July 2007

ASTRAZENECA UK LIMITED Appointed on 1 April 1999 Resigned on 31 July 2007

ASTRAZENECA TREASURY LIMITED Appointed on 29 August 2000 Resigned on 31 July 2007

APTIUM CANCER CARE LIMITED Appointed on 3 July 2006 Resigned on 31 July 2007

MEDIMMUNE LIMITED Appointed on 22 June 2006 Resigned on 27 July 2007

I.C. INSURANCE HOLDINGS LIMITED Appointed on 1 October 1997 Resigned on 24 March 2005

ASTRAZENECA INVESTMENTS LIMITED Appointed on 6 September 2000 Resigned on 1 December 2004

QINETIQ HOLDINGS LIMITED Appointed on 1 July 2001 Resigned on 30 June 2004

QINETIQ LIMITED Appointed on 25 April 2001 Resigned on 5 July 2002

SYNGENTA LIMITED Appointed on 1 October 1997 Resigned on 13 November 2000

By establishing ten identities he has ensured that any conflicts of interests or mutual interest can not be identified in any of the audits. This compromises the audits of all of his interests since his appointment to each firm and any due diligence to meet anti-money laundering and terrorism financing legislation.

Referring to his 2022 GSK register of interests, he fails to declare several active directorship; NATIONAL CENTRE FOR UNIVERSITIES AND BUSINESS, CONDORCET PARTNERS LIMITED, CONDORCET GP LLP, QUALITY BY RANDOMIZATION LIMITED, and EA GROUP HOLDINGS LTD.

Failing to disclose interests is an offence. Creating multiple identities involves falsifying the record (with different residential addresses in his case, or different spelling of the same one) which enable his interests to be concealed. I conclude that this is evidence of fraud by false representation and fraud by failing to disclose information.

Since he has compromised GSK's audit, in my opinion, he should resign. That he is your chairman means that the turnover of GSK, since you employed him, are proceeds of crime. GSK has a duty to report his breach of accountability and transparency, caused by his ten identities and his failure to declare interests, to the police for forensic investigation.

I've submitted a complaint to GSK.